Angioplasty and Stenting of Atherosclerotic Middle Cerebral Arteries with Wingspan: Evaluation of Clinical Outcome, Restenosis, and Procedure Outcome

References

1. 1.↵
   1. Bogousslavsky J,
   2. Barnett HJ,
   3. Fox AJ,
   4. et al

   . Atherosclerotic disease of the middle cerebral artery. Stroke 1986;17:1112–20

   Abstract/FREE Full Text
2. 2.↵
   1. Chimowitz MI,
   2. Kokkinos J,
   3. Strong J,
   4. et al

   . The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488–93

   Abstract/FREE Full Text
3. 3.↵
   1. Thijs VN,
   2. Albers GW

   . Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490–97

   Abstract/FREE Full Text
4. 4.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Howlett-Smith H,
   4. et al

   . Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

   CrossRefPubMedWeb of Science
5. 5.↵
   Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial— The EC/IC Bypass Study Group.N Engl J Med 1985;313:1191–200

   PubMedWeb of Science
6. 6.↵
   1. Rundek T,
   2. Elkind MS,
   3. Chen X

   . Increased early stroke recurrence among patients with extracranial and intracranial atherosclerosis: Northern Manhattan Stroke Study. Neurology 1998;50 (suppl 4):A75
7. 7.↵
   Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group.Stroke 1998;29:1389–92

   Abstract/FREE Full Text
8. 8.↵
   1. Caplan LR

   . Advances in stroke research: basic science, treatment, and clinical trial outcomes. Rev Neurol Dis 2004;2:91–94
9. 9.↵
   1. Kasner SE,
   2. Chimowitz MI,
   3. Lynn MJ,
   4. et al

   . Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555–63

   Abstract/FREE Full Text
10. 10.↵
    1. Qureshi AI,
    2. Feldmann E,
    3. Gomez CR,
    4. et al

    . Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging 2009;19 (suppl 1):1S–10S

    CrossRef
11. 11.↵
    1. Marks MP,
    2. Wojak JC,
    3. Al-Ali F,
    4. et al

    . Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016–20

    Abstract/FREE Full Text
12. 12.↵
    1. Bose A,
    2. Hartmann M,
    3. Henkes H,
    4. et al

    . A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531–37

    Abstract/FREE Full Text
13. 13.↵
    1. Mori T,
    2. Fukuoka M,
    3. Kazita K,
    4. et al

    . Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525–33

    Abstract
14. 14.↵
    1. Samuels OB,
    2. Joseph GJ,
    3. Lynn MJ,
    4. et al

    . A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643–46

    Abstract/FREE Full Text
15. 15.↵
    1. Levy EI,
    2. Turk AS,
    3. Albuquerque FC,
    4. et al

    . Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644–51

    PubMedWeb of Science
16. 16.↵
    1. Albuquerque FC,
    2. Levy EI,
    3. Turk AS,
    4. et al

    . Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery 2008;63:23–27

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Turk AS,
    2. Levy EI,
    3. Albuquerque FC,
    4. et al

    . Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008;29:23–27

    Abstract/FREE Full Text
18. 18.↵
    1. Fiorella D,
    2. Levy EI,
    3. Turk AS,
    4. et al

    . US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87

    Abstract/FREE Full Text
19. 19.↵
    1. Zaidat OO,
    2. Klucznik R,
    3. Alexander MJ,
    4. et al.,
    5. for the NIH Multi-Center Wingspan Intracranial Stent Registry Study Group

    . The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008;70:1518–24

    Abstract/FREE Full Text
20. 20.↵
    1. Nahab F,
    2. Lynn MJ,
    3. Kasner SE,
    4. et al

    . Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014–19

    Abstract/FREE Full Text